Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Prepaid Assets (2023 - 2025)

Zenas BioPharma has reported Prepaid Assets over the past 3 years, most recently at $8.0 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $8.0 million for Q4 2025, up 57.47% from a year ago — trailing twelve months through Dec 2025 was $8.0 million (up 57.47% YoY), and the annual figure for FY2025 was $8.0 million, up 57.47%.
  • Prepaid Assets for Q4 2025 was $8.0 million at Zenas BioPharma, up from $5.8 million in the prior quarter.
  • Over the last five years, Prepaid Assets for ZBIO hit a ceiling of $8.0 million in Q4 2025 and a floor of $2.9 million in Q4 2023.
  • Median Prepaid Assets over the past 3 years was $5.4 million (2025), compared with a mean of $5.6 million.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 71.94% in 2024 and later dropped 17.5% in 2025.
  • Zenas BioPharma's Prepaid Assets stood at $2.9 million in 2023, then skyrocketed by 71.94% to $5.1 million in 2024, then surged by 57.47% to $8.0 million in 2025.
  • The last three reported values for Prepaid Assets were $8.0 million (Q4 2025), $5.8 million (Q3 2025), and $5.3 million (Q2 2025) per Business Quant data.